Paula M Berguer

Title: Paula M. Berguer: Innovator in Chimeric Protein Research

Introduction

Paula M. Berguer is a notable inventor based in Arkansas, recognized for her contributions to the field of biochemistry and protein engineering. Her work primarily focuses on the development of isolated chimeric proteins, which have significant implications in vaccine development and immune response induction.

Latest Patents

Although Paula M. Berguer currently holds no patents, her research has led to the creation of innovative concepts such as isolated chimeric proteins of modified lumazine synthase. These proteins include multiple copies of peptides, polypeptides, or protein domains inserted into the Brucella spp. lumazine synthase enzyme. Her work encompasses isolated nucleotide sequences that code for these chimeric proteins, as well as vectors, plasmids, and transformed cells used for their expression. Additionally, she has explored the production of monoclonal and polyclonal antibodies induced by these proteins, hybridomas that produce these antibodies, and the development of vaccines and pharmaceutical compounds that incorporate the chimeric proteins and antibodies.

Career Highlights

Paula M. Berguer is currently associated with Goldgene LLC, where she continues her research and development efforts. Her innovative approach to protein engineering has the potential to advance therapeutic applications and improve vaccine efficacy.

Collaborations

Throughout her career, Paula has collaborated with esteemed colleagues such as Fernando A. Goldbaum and Diego A. Laplagne. These partnerships have enriched her research and contributed to the advancement of her projects.

Conclusion

Paula M. Berguer is a pioneering inventor in the realm of chimeric proteins, with a focus on their applications in immunology and biotechnology. Her ongoing research at Goldgene LLC promises to yield significant advancements in the field.